Anavex Life Sciences Corp (AVXL)

[polarbear77]

At some point though, someone with authority must recognize and voice the common sense point that Alzheimer’s Disease patients would PREFER their MMSE scores to drop by 1.1 rather than 4.4 over 2 years.

And that the current blarcamesine safety and side effects seem superior to aricept and aducanamab.

Alzheimer’s Association? Level headed biotech reporter? CNS researcher?

Hey Alzheimer’s Association, how about running a quick multiple choice poll in your next monthly magazine. Let’s see what the patients/caregivers have to say.